<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK548365" /><meta name="ncbi_domain" content="livertox" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK548365/" /><meta name="ncbi_pagename" content="Anticonvulsants - LiverTox - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Anticonvulsants - LiverTox - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]" /><meta name="citation_title" content="Anticonvulsants" /><meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="citation_date" content="2019/04/18" /><meta name="citation_pmid" content="31643686" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK548365/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Anticonvulsants" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="DC.Date" content="2019/04/18" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK548365/" /><meta name="description" content="Anticonvulsant medications include many agents that have been incriminated in causing idiosyncratic drug induced liver disease. Indeed, several commonly used anticonvulsants (phenytoin, valproate, carbamazepine) are consistently ranked in the top causes of clinically apparent drug induced liver injury and are frequently listed in causes of drug induced acute liver failure. Because of the importance of pharmacotherapy of epilepsy, the potential hepatotoxicity of these agents has been considered acceptable. Nevertheless, attempts at developing safer agents of equivalent or superior efficacy continue." /><meta name="og:title" content="Anticonvulsants" /><meta name="og:type" content="book" /><meta name="og:description" content="Anticonvulsant medications include many agents that have been incriminated in causing idiosyncratic drug induced liver disease. Indeed, several commonly used anticonvulsants (phenytoin, valproate, carbamazepine) are consistently ranked in the top causes of clinically apparent drug induced liver injury and are frequently listed in causes of drug induced acute liver failure. Because of the importance of pharmacotherapy of epilepsy, the potential hepatotoxicity of these agents has been considered acceptable. Nevertheless, attempts at developing safer agents of equivalent or superior efficacy continue." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK548365/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/livertox/Anticonvulsants/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK548365/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88E83104658A710000000007210211.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All Drug Records" href="/books/n/livertox/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" alt="Cover of LiverTox" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK548365_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK548365_dtls__"><div>Bethesda (MD): <a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>; 2012-.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/livertox/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Anticholinergics/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Antidepressants/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK548365_"><span class="title" itemprop="name">Anticonvulsants</span></h1><p class="small">Last Update: <span itemprop="dateModified">April 18, 2019</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="Anticonvulsants.OVERVIEW"><h2 id="_Anticonvulsants_OVERVIEW_">OVERVIEW</h2><p>Anticonvulsant medications include many agents that have been incriminated in causing idiosyncratic drug induced liver disease. Indeed, several commonly used anticonvulsants (phenytoin, valproate, carbamazepine) are consistently ranked in the top causes of clinically apparent drug induced liver injury and are frequently listed in causes of drug induced acute liver failure. Because of the importance of pharmacotherapy of epilepsy, the potential hepatotoxicity of these agents has been considered acceptable. Nevertheless, attempts at developing safer agents of equivalent or superior efficacy continue.</p><p>Major anticonvulsants include hydantoin derivatives, barbiturates, benzodiazepines, succinimides, valproic acid, gamma amino butyric acid (GABA) precursors and analogues, inhibitors of DMDA receptors and a multitude of miscellaneous recently introduced agents. At least two dozen agents are licensed and approved for use as anticonvulsants in the United States. The anticonvulsants that are available in the United States, the likelihood score for hepatotoxicity, their year of introduction or approval and their major approved indications are shown in the Table which includes links to the individual agents with the full description and discussion of their potential for hepatotoxicity.</p><p>Phenobarbital is the oldest antiepileptic medication still in use, having been introduced into clinical medicine in 1916. Phenobarbital is an aromatic anticonvulsant and, like phenytoin and carbamazepine, can cause the aromatic anticonvulsant hypersensitivity syndrome, a form of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Questions remain regarding the anticonvulsant efficacy of phenobarbital and it is now rarely used for this indication.</p><p>Phenytoin, formerly known as diphenylhydantoin, was introduced into use as an anticonvulsant in 1938 and remains one of the most commonly used medications for epilepsy. Fosphenytoin is an intravenous formulation of phenytoin that has been available since 1995 and is used for status epilepticus and as a substitute for oral phenytoin during surgery. Phenytoin is a well known cause of acute liver injury, which is usually part of the anticonvulsant hypersensitivity syndrome and can be severe and lead to acute liver failure and death.</p><p>Carbamazepine was introduced into use in 1963 for treatment of generalized seizures and with other carbamazepines (oxcarbazepine, eliscarbazepine) is still widely used. Carbamazepine can also cause the anticonvulsant hypersensitivity syndrome and is a well known cause of acute drug induced liver injury as well as serious cutaneous reactions such as <a class="def" href="/books/n/livertox/glossary/def-item/glossary.stevensjohnson-syndrome/">Stevens-Johnson syndrome</a> and toxic epidermal necrolysis.</p><p>Lamotrigine is a more recently developed anticonvulsant that has broad antiseizure activity. Lamotrigine can also cause the anticonvulsant hypersensitivity syndrome and has become one of the most common causes of clinically apparent drug-induced liver injury.</p><p>The benzodiazepines are both anxiolytic and antiepileptic and several including diazepam, clonazepam and clorazepate are used in the therapy of epilepsy. Benzodiazepines are also discussed under the antianxiolytic medications. They appear to act by enhancing gamma aminobutyric acid (GABA) receptor activity. While many benzodiazepines have antiseizure activity, only clonazepam and clorazepate are commonly used in long term treatment of epilepsy. Diazepam and other parentally administered benzodiazepams are also used for therapy of status epilepticus. Benzodiazepines have only rarely been implicated in causing drug induced liver injury and have not been implicated in the anticonvulsant hypersensitivity syndrome.</p><p>The succinimides are active against clonic motor seizures and absence seizures (petit mal) in humans. This class includes ethosuximide (1960) and methsuximide (1957).</p><p>Valproic acid or valproate is a branched chain carboxylic acid that was found to have antiseizure activity somewhat by accident. Valproate was introduced in 1978 and rapidly became a commonly used agent for partial seizures and for poorly controlled generalized seizures. Valproic acid is also used in the treatment of mood and bipolar disorders. Valproate can cause several distinctive forms of liver injury, ranging from asymptomatic serum aminotransferase elevations to an acute hepatitis which can be severe and even fatal, to a Reye syndrome like syndrome of hepatic dysfunction and microvesicular fatty liver. High doses of valproic acid can also cause stupor and coma from hyperammonemia without accompanying severe liver injury.</p><p>Topiramate is a sulfamate-substituted monosaccharide and unique and broadly active anticonvulsant introduced in 1996 that is still widely used. Topiramate is also used for prevention of migraine headaches, as a weight loss agent and (off label) for mood disorders and bipolar illness.</p><p>Levetiracetam is a pyrrolidine derivative and unique anticonvulsant introduced in 1999 that has been increasing used because of its safety and excellent tolerability. Levetiracetam binds to the synaptic vesicle glycoprotein SV2A and appears to act by inhibiting calcium channels which participate in neurotransmitter release. Levetiracetam has been linked to rare instances of drug induced liver disease, but not with the anticonvulsant hypersensitivity syndrome. Brivaracetam is an anticonvulsant of similar structure and activity was approved in 2016.</p><p>Other agents active against seizures have been developed in recent years, many of which act by uncertain mechanisms and which belong to different classes of agents. These agents, their likelihood score, year of approval and major indications are given below.</p><div id="Anticonvulsants.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548365/table/Anticonvulsants.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Anticonvulsants.Tc_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><td colspan="4" scope="col" rowspan="1" style="text-align:center;vertical-align:middle;"><b>ANTICONVULSANTS*</b></td></tr><tr><th id="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Generic Name<br /> Brand Name</th><th id="hd_b_Anticonvulsants.Tc_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Likelihood Score</th><th id="hd_b_Anticonvulsants.Tc_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Approval</th><th id="hd_b_Anticonvulsants.Tc_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Major Indications</th></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/livertox/Brivaracetam/">Brivaracetam</a><br /> Briviact</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2016</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial seizures</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/livertox/Cannabidiol/">Cannabidiol</a><br /> Epidiolex</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E*</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2018</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures associated with Lennox-Gastaut or Dravet syndrome</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/livertox/Carbamazepine/">Carbamazepine</a><br /> Tegretol</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">A</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1968</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial, mixed and generalized seizures, trigeminal neuralgia</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/livertox/Clobazam/">Clobazam</a><br /> Onfi</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2011</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures associated with Lennox-Gastaut syndrome</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Clonazepam/">Clonazepam</a><br /> Klonopin</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">D</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1975</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absence and myoclonic seizures, anxiety and panic disorders</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Clorazepate/">Clorazepate</a><br /> Tranxene</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1972</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial seizures, anxiety disorders, and alcohol withdrawal</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/livertox/DiazepamIV/">Diazepam</a><br /> Valium</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1963</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Convulsions, anxiety disorders, muscle spasms</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/livertox/Eslicarbazepine/">Eslicarbazepine</a><br /> Aptiom</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">D</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2013</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial seizures</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Ethosuximide/">Ethosuximide</a><br /> Zarontin</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1960</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absence seizures</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Ezogabine/">Ezogabine</a><br /> Potiga</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2011</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial seizures</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Felbamate/">Felbamate</a><br /> Febatol</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">B</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1993</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refractory or severe epilepsy</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Fosphenytoin/">Fosphenytoin</a><br /> Cerebyx</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">A</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1996</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tonic-clonic seizures, status epilepticus</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Gabapentin/">Gabapentin</a><br /> Neurontin</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">C</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1993</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial seizures, post-herpetic neuralgia</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/livertox/Lacosamide/">Lacosamide</a><br /> Vimpat</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">D</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2008</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial seizures</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Lamotrigine/">Lamotrigine</a><br /> Lamictal</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">A</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1994</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial and generalized tonic-clonic seizures, bipolar disorder</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Levetiracetam/">Levetiracetam</a><br /> Keppra</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">C</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1999</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial, generalized tonic-clonic, and myoclonic seizures</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/livertox/Methsuximide/">Methsuximide</a><br /> Celontin</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1957</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absence seizures</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Oxcarbazepine/">Oxcarbazepine</a><br />Trileptal</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">D</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2000</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial seizures</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/livertox/Perampanel/">Perampanel</a><br /> Fycompa</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2012</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial and generalized tonic-clonic seizures</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Phenobarbital/">Phenobarbital</a><br /> Luminal</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">B</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1916</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial and generalized seizures, anxiety, and irritable bowel syndrome</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Phenytoin/">Phenytoin</a><br />Dilantin</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">A</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1938</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Generalized tonic-clonic and partial onset seizures, status epilepticus</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Pregabalin/">Pregabalin</a><br /> Lyrica</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">C</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2004</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial seizures, fibromyalgia, and neuropathic pain</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Primidone/">Primidone</a><br /> Mysoline</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E*</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1954</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial and generalized tonic-clonic seizures</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/livertox/Rufinamide/">Rufinamide</a><br /> Banzel</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E*</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2008</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures associated with Dravet syndrome</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/livertox/Stiripentol/">Stiripentol</a><br /> Diacomit</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2018</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures associated with Dravet syndrome</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Tiagabine/">Tiagabine</a><br /> Gabitril</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">E</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1997</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial seizures</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Topiramate/">Topiramate</a><br /> Topamax</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">C</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1996</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial and generalized tonic-clonic seizures, migraine headaches</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/livertox/Valproate/">Valproate</a><br /> Depakene</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">A</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1978</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absence and complex partial seizures</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Vigabatrin/">Vigabatrin</a><br /> Sabril</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">D</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2009</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refractory, complex partial seizures, and infantile spasms</td></tr><tr><td headers="hd_b_Anticonvulsants.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/livertox/Zonisamide/">Zonisamide</a><br /> Zonegran</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">D</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2000</td><td headers="hd_b_Anticonvulsants.Tc_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial seizures</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>* </dt><dd><div id="Anticonvulsants.TF.c.1"><p class="no_margin">Underlined Name indicates the availability of a LiverTox record.</p></div></dd></dl></div></div></div></div><div id="Anticonvulsants.ANNOTATED_BIBLIOGRAPHY"><h2 id="_Anticonvulsants_ANNOTATED_BIBLIOGRAPHY_">ANNOTATED BIBLIOGRAPHY</h2><p>References updated: 18 April 2019</p><ul class="first-line-outdent"><li><div class="bk_ref" id="Anticonvulsants.REF.zimmerman.1999">Zimmerman HJ. Anticonvulsants. In, Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott, 1999, pp. 498-516.<div><i>(Expert review of anticonvulsants and liver injury published in 1999).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.pirmohamed.2013">Pirmohamed M, Leeder SJ. Anticonvulsant agents. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013: pp 423-42.<div><i>(Review of anticonvulsant induced liver injury).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.smith.2018">Smith MD, Metcalf CS, Wilcox KS. Pharmacotherapy of the epilepsies. In, Brunton LL, Hilal-Dandan R, Knollman BC, eds. Goodman &#x00026; Gilman's the pharmacological basis of therapeutics. 13th ed. New York: McGraw-Hill, 2018, pp. 303-26.<div><i>(Textbook of pharmacology and therapeutics).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.wallace.1996.378">Wallace SJ. A comparative review of the adverse effects of anticonvulsants in children with epilepsy. <span><span class="ref-journal">Drug Saf. </span>1996;<span class="ref-vol">15</span>:378–93.</span> [<a href="/pubmed/8968693" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8968693</span></a>]<div><i>(Systematic review; ALT elevations occur in 4% of children on phenytoin, 6% on valproate, 1% on carbamazepine and rarely with tiagabine or gabapentin; no mention of hepatotoxicity of topiramate).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.hamer.1999.239">Hamer HM, Morris HH. Hypersensitivity syndrome to antiepileptic drugs: a review including new anticonvulsants. <span><span class="ref-journal">Cleve Clin J Med. </span>1999;<span class="ref-vol">66</span>:239–45.</span> [<a href="/pubmed/10199060" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10199060</span></a>]<div><i>(Clinical review: hypersensitivity occurs in 1 to 5 per 10,000 users with a higher risk in African Americans and affected siblings; liver involvement common, but most cases are anicteric; other manifestations include facial edema, lymphadenopathy, bone marrow aplasia, pseudolymphoma, thyroiditis, interstitial nephritis; switching to valproate and benzodiazepines is safe, levetiracetam is also an option).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.wilby.2005.1">Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, et al.  Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. <span><span class="ref-journal">Health Technol Assess. </span>2005;<span class="ref-vol">9</span>:1–157.</span> iii-iv. [<a href="/pubmed/15842952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15842952</span></a>]<div><i>(Extensive systematic review of anticonvulsant medications including assessment of serious, rare and long term adverse events; focusing on gabapentin, lamotrigine, oxcarbazepine, tiagabine, topiramate and vigabatrin).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.laroche.2007.133">LaRoche SM. A new look at the second-generation antiepileptic drugs: a decade of experience. <span><span class="ref-journal">Neurologist. </span>2007;<span class="ref-vol">13</span>:133–9.</span> [<a href="/pubmed/17495757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17495757</span></a>]<div><i>(Review of second generation anticonvulsants approved since 1994 including felbamate, gabapentin, lamotrigine, pregabalin, topiramate, tiagabine, levetiracetam, oxcarbazepine and zonisamide; Stevens-Johnson syndrome is associated with lamotrigine and oxcarbazepine, no mention of liver toxicity from the other agents).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.chalasani.2008.1924">Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J., Drug Induced Liver Injury Network (DILIN).  Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. <span><span class="ref-journal">Gastroenterology. </span>2008;<span class="ref-vol">135</span>:1924–34.</span> [<a href="/pmc/articles/PMC3654244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3654244</span></a>] [<a href="/pubmed/18955056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18955056</span></a>]<div><i>(Among 300 cases of drug induced liver disease in the US collected between 2004 and 2008, valproate accounted for 6, lamotrigine 5, phenytoin 5, gabapentin and topiramate 1 each, but details not provided).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.bj_rnsson.2008.281">Bj&#x000f6;rnsson E. Hepatotoxicity associated with antiepileptic drugs. <span><span class="ref-journal">Acta Neurol Scand. </span>2008;<span class="ref-vol">118</span>:281–90.</span> [<a href="/pubmed/18341684" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18341684</span></a>]<div><i>(Review of anticonvulsant induced liver injury).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.reuben.2010.2065">Reuben A, Koch DG, Lee WM., Acute Liver Failure Study Group.  Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. <span><span class="ref-journal">Hepatology. </span>2010;<span class="ref-vol">52</span>:2065–76.</span> [<a href="/pmc/articles/PMC3992250/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3992250</span></a>] [<a href="/pubmed/20949552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20949552</span></a>]<div><i>(Among 1198 patients with acute liver failure enrolled in a US prospective study between 1998 and 2007, 133 were attributed to drug induced liver injury including 13 [10%] due to anticonvulsants: phenytoin 8, carbamazepine 3 and valproate 2).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.ferrajolo.2010.721">Ferrajolo C, Capuano A, Verhamme KM, Schuemie M, Rossi F, Stricker BH, Sturkenboom MC. Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase. <span><span class="ref-journal">Br J Clin Pharmacol. </span>2010;<span class="ref-vol">70</span>:721–8.</span> [<a href="/pmc/articles/PMC2997312/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2997312</span></a>] [<a href="/pubmed/21039766" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21039766</span></a>]<div><i>(Worldwide pharmacovigilance database contained 9036 hepatic adverse drug reactions in children, 7 anticonvulsants were listed among the top 41 causes: valproate [208 cases, ranking 3rd] carbamazepine [140, 4th], lamotrigine [112, 7th], phenytoin [57, 20th], topiramate [51, 22nd], oxcarbazepine [43, 28th], phenobarbital [41, 32nd]).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.devarbhavi.2011.1344">Devarbhavi H, Karanth D, Prasanna KS, Adarsh CK, Patil M. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents. <span><span class="ref-journal">Hepatology. </span>2011;<span class="ref-vol">54</span>:1344–50.</span> [<a href="/pubmed/21735470" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21735470</span></a>]<div><i>(Among 39 children with drug induced liver disease seen at a single referral center in India between 2005 and 2010, 10 cases were due to phenytoin and 6 to carbamazepine, all of whom survived in contrast to deaths of 12 of 23 children with hepatocellular injury without signs of hypersensitivity [largely due to antituberculosis medications]).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.molleston.2011.182">Molleston JP, Fontana RJ, Lopez MJ, Kleiner DE, Gu J, Chalasani N., Drug-Induced Liver Injury Network.  Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN Prospective Study. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2011;<span class="ref-vol">53</span>:182–9.</span> [<a href="/pmc/articles/PMC3634369/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3634369</span></a>] [<a href="/pubmed/21788760" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21788760</span></a>]<div><i>(Among 30 children with drug induced liver injury enrolled in a prospective US database between 2004 and 2008, 8 were due to anticonvulsants [lamotrigine in 3, valproate in 3, phenytoin in 1 and carbamazepine in 1], none of which were fatal or led to chronic injury).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.kwon.2012.268">Kwon H, Lee SH, Kim SE, Lee JH, Jee YK, Kang HR, Park BJ, Park JW, Hong CS. Spontaneously reported hepatic adverse drug events in Korea: multicenter study. <span><span class="ref-journal">J Korean Med Sci. </span>2012;<span class="ref-vol">27</span>:268–73.</span> [<a href="/pmc/articles/PMC3286773/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3286773</span></a>] [<a href="/pubmed/22379337" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22379337</span></a>]<div><i>(Summary of 2 years of adverse event reporting in Korea; of 9360 reports, 567 were liver related, including 55 [10%] attributed to anticonvulsants: 33 to valproate, 8 topiramate, 6 carbamazepine, 2 lamotrigine, 2 gabapentin and 1 phenytoin).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF15">Drugs for epilepsy. <span><span class="ref-journal">Treat Guidel Med Lett. </span>2013;<span class="ref-vol">11</span>:9–18.</span> Erratum in Treat Guidel Med Lett 2013; 11: 112. [<a href="/pubmed/23348233" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23348233</span></a>]<div><i>(Concise review of drugs of choice for epilepsy with discussion of clinical indications, adverse effects).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.bj_rnsson.2013.1419">Bj&#x000f6;rnsson ES, Bergmann OM, Bj&#x000f6;rnsson HK, Kvaran RB, Olafsson S. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. <span><span class="ref-journal">Gastroenterology. </span>2013;<span class="ref-vol">144</span>:1419–25.</span> [<a href="/pubmed/23419359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23419359</span></a>]<div><i>(In a population based study of drug induced liver injury from Iceland, 96 cases were identified over a 2 year period, including 3 attributed to anticonvulsants: 2 due to phenytoin and 1 to gabapentin).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.hern_ndez.2014.231">Hern&#x000e1;ndez N, Bessone F, S&#x000e1;nchez A, di Pace M, Brahm J, Zapata R, A, Chirino R, et al.  Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports. <span><span class="ref-journal">Ann Hepatol. </span>2014;<span class="ref-vol">13</span>:231–9.</span> [<a href="/pubmed/24552865" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24552865</span></a>]<div><i>(Systematic review of literature of drug induced liver injury in Latin American countries published from 1996 to 2012 identified 176 cases, 7 of which were due to anticonvulsants: 3 due to valproate, 3 phenytoin and 1 carbamazepine).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.chalasani.2015.1340">Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, et al. United States Drug Induced Liver Injury Network.  Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. <span><span class="ref-journal">Gastroenterology. </span>2015;<span class="ref-vol">148</span>:1340–52.e7.</span> [<a href="/pmc/articles/PMC4446235/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4446235</span></a>] [<a href="/pubmed/25754159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25754159</span></a>]<div><i>(Among 899 cases of drug induced liver injury enrolled in a US prospective study between 2004 and 2013, 40 [4.5%] were attributed to anticonvulsant agents including 12 to phenytoin, 9 lamotrigine, 7 valproic acid, 4 carbamazepine, 3 gabapentin, 2 topiramate, 1 pregabalin, 1 ethosuximide, and 1 fosphenytoin).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF19">Drugs for epilepsy. <span><span class="ref-journal">Med Lett Drugs Ther. </span>2017;<span class="ref-vol">59</span>(1526):121–30.</span> [<a href="/pubmed/28746301" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28746301</span></a>]<div><i>(Concise review of the drugs available for therapy of epilepsy including brief summary of adverse events with each).</i></div></div></li><li><div class="bk_ref" id="Anticonvulsants.REF.vidaurre.2017.23">Vidaurre J, Gedela S, Yarosz S. Antiepileptic drugs and liver disease. <span><span class="ref-journal">Pediatr Neurol. </span>2017;<span class="ref-vol">77</span>:23–36.</span> [<a href="/pubmed/29097018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29097018</span></a>]<div><i>(Review of the use of anticonvulsants in patients with liver disease recommends use of agents that have little hepatic metabolism such as levetiracetam, lacosamide, topiramate, gabapentin and pregabalin, lacosamide being a good choice because of linear pharmacokinetics, only partial hepatic metabolism, with inactive metabolites and lack of clinically significant CYP450 interactions).</i></div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK548365</span><span class="label">PMID: <a href="/pubmed/31643686" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31643686</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Anticholinergics/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Antidepressants/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK548365&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK548365/?report=reader">PubReader</a></li><li><a href="/books/NBK548365/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK548365" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK548365" style="display:none" title="Cite this Page"><div class="bk_tt">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.  Anticonvulsants. [Updated 2019 Apr 18].<span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK548365/pdf/Bookshelf_NBK548365.pdf">PDF version of this page</a> (101K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Bulk Download</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://ftp.ncbi.nlm.nih.gov/pub/litarch/29/31/" ref="pagearea=source-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Bulk download LiverTox data from FTP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Overviews</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/intro/">Introduction</a></li><li><a href="/books/n/livertox/Causality/">Causality</a></li><li><a href="/books/n/livertox/ClinicalCourse/">Clinical Course</a></li><li><a href="/books/n/livertox/ClinicalOutcome/">Clinical Outcomes</a></li><li><a href="/books/n/livertox/ImmuneFeatures/">Immune Features</a></li><li><a href="/books/n/livertox/DrugCategory/">Likelihood Scale</a></li><li><a href="/books/n/livertox/Phenotypes_intro/">Phenotypes</a></li><li><a href="/books/n/livertox/Severity/">Severity Grading</a></li><li><a href="/books/n/livertox/CaseReport/">Writing a Case Report</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Support Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/">LiverTox Homepage</a></li><li><a href="/books/n/livertox/aboutus/">About LiverTox</a></li><li><a href="/books/n/livertox/editorsandreviewers/">Editors and Review Committee</a></li><li><a href="/books/n/livertox/alert/">Meetings and News</a></li><li><a href="/books/n/livertox/abbreviation/">Abbreviations Used</a></li><li><a href="/books/n/livertox/glossary/">Glossary</a></li><li><a href="/books/n/livertox/resource/">Information Resources</a></li><li><a href="/books/n/livertox/disclaimer/">User/Medical Advice Disclaimer</a></li><li><a href="/books/n/livertox/Contactus/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4860442" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4860442" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17165282" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents.</a><span class="source">[Ann Allergy Asthma Immunol. 2006]</span><div class="brieflinkpop offscreen_noflow">Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Seitz CS, Pfeuffer P, Raith P, Bröcker EB, Trautmann A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Allergy Asthma Immunol. 2006 Nov; 97(5):698-702. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20826140" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model.</a><span class="source">[Eur J Pharmacol. 2010]</span><div class="brieflinkpop offscreen_noflow">Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Luszczki JJ, Cioczek JD, Kocharov SL, Andres-Mach M, Kominek M, Zolkowska D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Pharmacol. 2010 Dec 1; 648(1-3):74-9. Epub 2010 Sep 6.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/32117699" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Valproate-induced Drug Rash Eosinophilia with Systemic Symptoms Syndrome: An Unknown Hepatotoxicity.</a><span class="source">[Euroasian J Hepatogastroentero...]</span><div class="brieflinkpop offscreen_noflow">Valproate-induced Drug Rash Eosinophilia with Systemic Symptoms Syndrome: An Unknown Hepatotoxicity.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gupta T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Euroasian J Hepatogastroenterol. 2019 Jul-Dec; 9(2):102-103. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/2871724" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Anticonvulsant drugs: mechanisms of action.</a><span class="source">[Adv Neurol. 1986]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Anticonvulsant drugs: mechanisms of action.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Macdonald RL, McLean MJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Adv Neurol. 1986; 44:713-36. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12269862" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.</a><span class="source">[CNS Drugs. 2002]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Perucca E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">CNS Drugs. 2002; 16(10):695-714. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31643686" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31643686" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="&#10;                        HTOn&#10;                    "><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2021-03-08T14:11:47-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@9.2&amp;Host=portal101&amp;ncbi_phid=CE88E83104658A710000000007210211&amp;ncbi_session=CE88E83104676F11_1825SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK548365%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK548365&amp;ncbi_domain=livertox&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK548365/&amp;ncbi_pagename=Anticonvulsants - LiverTox - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88E83104676F11_1825SID /projects/books/PBooks@9.2 portal101 v4.1.r621975 Fri, Dec 18 2020 02:56:50 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>